These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37076740)

  • 1. Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration.
    Anwar MN; Hickson RI; Mehra S; Price DJ; McCaw JM; Flegg MB; Flegg JA
    Bull Math Biol; 2023 Apr; 85(6):43. PubMed ID: 37076740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of P. vivax elimination via mass drug administration: A simulation study.
    Anwar MN; McCaw JM; Zarebski AE; Hickson RI; Flegg JA
    Epidemics; 2024 Sep; 48():100789. PubMed ID: 39255654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
    Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
    J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multiscale Mathematical Model of Plasmodium Vivax Transmission.
    Anwar MN; Hickson RI; Mehra S; McCaw JM; Flegg JA
    Bull Math Biol; 2022 Jul; 84(8):81. PubMed ID: 35778540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China.
    Yang GJ; Shang LY; Zhou XN; Lee TE; Bi B; White M; Smith TA; Penny MA
    BMC Med; 2022 Jan; 20(1):17. PubMed ID: 35057816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
    Nekkab N; Lana R; Lacerda M; Obadia T; Siqueira A; Monteiro W; Villela D; Mueller I; White M
    PLoS Med; 2021 Apr; 18(4):e1003535. PubMed ID: 33891582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical models of Plasmodium vivax transmission: A scoping review.
    Anwar MN; Smith L; Devine A; Mehra S; Walker CR; Ivory E; Conway E; Mueller I; McCaw JM; Flegg JA; Hickson RI
    PLoS Comput Biol; 2024 Mar; 20(3):e1011931. PubMed ID: 38483975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of relapsing Plasmodium vivax malaria.
    Chu CS; White NJ
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Activation-Clearance Model for Plasmodium vivax Malaria.
    Mehra S; McCaw JM; Flegg MB; Taylor PG; Flegg JA
    Bull Math Biol; 2020 Feb; 82(2):32. PubMed ID: 32052192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
    Robinson LJ; Wampfler R; Betuela I; Karl S; White MT; Li Wai Suen CS; Hofmann NE; Kinboro B; Waltmann A; Brewster J; Lorry L; Tarongka N; Samol L; Silkey M; Bassat Q; Siba PM; Schofield L; Felger I; Mueller I
    PLoS Med; 2015 Oct; 12(10):e1001891. PubMed ID: 26505753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for malaria treatment evaluation in the presence of multiple species.
    Walker CR; Hickson RI; Chang E; Ngor P; Sovannaroth S; Simpson JA; Price DJ; McCaw JM; Price RN; Flegg JA; Devine A
    Epidemics; 2023 Sep; 44():100687. PubMed ID: 37348379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review.
    Drysdale M; Tan L; Martin A; Fuhrer IB; Duparc S; Sharma H
    Infect Dis Ther; 2023 Jan; 12(1):33-51. PubMed ID: 36378465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
    Phommasone K; van Leth F; Peto TJ; Landier J; Nguyen TN; Tripura R; Pongvongsa T; Lwin KM; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Nguon C; Davoeung C; Rekol H; Adhikari B; Promnarate C; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Cheah PY; Dhorda M; Imwong M; Mukaka M; Peerawaranun P; Pukrittayakamee S; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Cobelens F; Dondorp AM; White NJ; von Seidlein L
    PLoS One; 2020; 15(2):e0228190. PubMed ID: 32023293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.
    Ebstie YA; Abay SM; Tadesse WT; Ejigu DA
    Drug Des Devel Ther; 2016; 10():2387-99. PubMed ID: 27528800
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
    Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
    [No Abstract]   [Full Text] [Related]  

  • 19. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
    Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
    Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of G6PD testing and primaquine for
    Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
    WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.